首页> 外文期刊>Iranian Journal of Nuclear Medicine >Changes in salivary gland function following radioiodine therapy of thyroid diseases: A comparison of high-dose therapy for thyroid cancer and low-dose therapy for benign thyroid disease
【24h】

Changes in salivary gland function following radioiodine therapy of thyroid diseases: A comparison of high-dose therapy for thyroid cancer and low-dose therapy for benign thyroid disease

机译:放射性碘治疗甲状腺疾病后唾液腺功能的变化:甲状腺癌大剂量治疗与良性甲状腺疾病小剂量治疗的比较

获取原文
           

摘要

Introduction: High-dose radioactive iodine therapy in differentiated thyroid cancer (DTC) may adversely affect the salivary gland function. This study is aimed to evaluate the effect of radioactive iodine (RAI) with dose of 100 mCi in DTC patients compared to lower doses of less than 30 mCi in hyperthyroid cases. Methods: Fifty four patients (13 men and 41 women) age: 42.3±14.3 (21-71) years were enrolled in the study. Twenty seven hyperthyroid cases received less than 30 mCi of I-131 for the treatment, and 27 DTC patients were treated with 100 mCi of I-131. All patients underwent Tc-99m pertechnetate scintigraphy before and three months after radioiodine therapy. Salivary gland excretion fractions (EF) were compared between groups. A decrease of more than 5% in EF was considered significant. Results: The total frequency of salivary dysfunction was 41.7%. In patients received a dosage of 100 mCi of I-131, this frequency was 49.1%, while with less than 30 mCi, it was 34.3% (p
机译:简介:大剂量放射性碘治疗分化型甲状腺癌(DTC)可能会对唾液腺功能产生不利影响。这项研究旨在评估DTC患者中100 mCi剂量的放射性碘(RAI)的效果,而甲状腺功能亢进病例中低于30 mCi的较低剂量的效果。方法:54名患者(13名男性和41名女性)年龄:42.3±14.3(21-71)岁。 27例甲状腺功能亢进患者接受了小于30 mCi的I-131治疗,而27例DTC患者接受了100 mCi的I-131治疗。所有患者在放射碘治疗之前和之后三个月接受Tc-99m高tech酸盐闪烁显像。比较各组的唾液腺排泄分数(EF)。 EF降低超过5%被认为是显着的。结果:唾液功能障碍的总发生率为41.7%。在接受100 mCi I-131剂量的患者中,此频率为49.1%,而小于30 mCi的患者为34.3%(p

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号